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Objectives The aim of our prospective study was to assess the
ability of different parameters to identify fetuses requiring neonatal
care for coarctation of the aorta (CoA).
Methods Between January 2003 and December 2012, 175 fetuses
of our region referred for great vessel disproportion (pulmonary
valve/aortic valve (AoV) diameter ratio≥ 1.6) were divided into
two groups: group A (n = 51) with high risk of CoA and deliv-
ery planned in tertiary care referral center; group B (n = 124)
with no increased risk of CoA. Fetuses with Z-score aortic
valve AoV <−2 at 36weeks of amenorrhea (WA) (measurements
of AoV were normalized to femoral length with Schneider’s Z-
score equation) or with hypoplastic and/or angular aortic arches
were considered at high risk of CoA and therefore in group A.
Fetuses with at least 2minor criteria: diagnosis before 28WA,
Z-score AoV <−1.2, ventricular septal defect and bicuspid AoV
were also included in group A. Persistent left superior vena
cava (LSVC) was not considered high risk, but was reported. All
neonates in the 2 groups had completed postnatal follow-up with
echocardiography.
Results In group A, diagnosis of CoA was conﬁrmed in 38/51 (75%)
and isolated CoA in 22/34 (65%). In group B, 2/124 had CoA (false
negative rate 1.6%). In univariate analysis, except for the LSVC, all
parameters were signiﬁcant (P < 0.001) but had, if isolated, poor
speciﬁcity. With our criteria, the positive predictive value was 75%
when vessels disproportion was noted before 28WA and 78% in the
third trimester. 51% of all CoA had not been referred and was diag-
nosed after birth.
Conclusion The results of our prospective study are in agreement
with those of previous series but our false positive rate is lower and
not inﬂuenced by gestational age. The performance of fetal cardiac
screening does not seem to be very good but prenatal diagnosis is
probably not always possible: our 2 false negative cases had vascular
disproportion without any other risk factors.
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Objectives This study was design to assess the inﬂuence of
extracardiac or chromosomal anomalies on parental decision of
termination of pregnancy and on survival rates in newborns with
prenatally diagnosed congenital heart diseases.
Methods and results 2057 consecutive foetuses with congenital
heart disease diagnosed from January 2002 to December 2011 were
included: 1258 (61%) in-born neonates and 799 (39%) terminations
of pregnancy (TOP). The overall prevalence of major extracardiac
or chromosomal anomalies was 18.6%. Of the 1258 newborns, 121
had a major associated anomaly but only 55 were identiﬁed before
birth. Prenatally identiﬁed associated anomalies were signiﬁcantly
lower in the newborn group in comparison with the TOP group (4%
vs. 31%, P < 0.0001). They were also lower in the surviving group at
one year of follow-up (7.5% vs. 20.7%, P < 0.0001). A 4-fold increase
of death rate was observed if an associated anomaly was identiﬁed
(IC95%[2.5—6.7], P < 0.0001). These associations remained signiﬁ-
cant after multiple logistic regression analysis including the severity
of the heart defect (univentricular or biventricular physiology).
Conclusion Women are more likely to terminate pregnancy if
extracardiac or chromosomal anomalies are associated. Postnatal
survival is strongly inﬂuenced by these associated anomalies.
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